Home/Filings/4/0001181431-12-055698
4//SEC Filing

Cermak Elizabeth 4

Accession 0001181431-12-055698

CIK 0001059790other

Filed

Oct 25, 8:00 PM ET

Accepted

Oct 26, 7:28 PM ET

Size

4.7 KB

Accession

0001181431-12-055698

Insider Transaction Report

Form 4
Period: 2012-10-25
Cermak Elizabeth
EVP, Chief Commercial Officer
Transactions
  • Award

    Common Stock

    2012-10-25+21,00021,000 total
Footnotes (1)
  • [F1]Restricted stock units granted pursuant to the POZEN Inc. 2010 Omnibus Equity Compensation Plan, which vests one-half (1/2) upon the acceptance by the FDA of the filing of an NDA for a low dose PA product, currently PA8140, and (b) one-half (1/2) upon approval by the FDA of an NDA for a low dose PA product, currently PA8140.

Issuer

POZEN INC /NC

CIK 0001059790

Entity typeother

Related Parties

1
  • filerCIK 0001471971

Filing Metadata

Form type
4
Filed
Oct 25, 8:00 PM ET
Accepted
Oct 26, 7:28 PM ET
Size
4.7 KB